FR2275214A1 - Procede de production de preparations de cephalosporine - Google Patents

Procede de production de preparations de cephalosporine

Info

Publication number
FR2275214A1
FR2275214A1 FR7325666A FR7325666A FR2275214A1 FR 2275214 A1 FR2275214 A1 FR 2275214A1 FR 7325666 A FR7325666 A FR 7325666A FR 7325666 A FR7325666 A FR 7325666A FR 2275214 A1 FR2275214 A1 FR 2275214A1
Authority
FR
France
Prior art keywords
oxyethylene
poly
cephalosporin
suppositories
ethers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7325666A
Other languages
English (en)
French (fr)
Other versions
FR2275214B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2275214A1 publication Critical patent/FR2275214A1/fr
Application granted granted Critical
Publication of FR2275214B1 publication Critical patent/FR2275214B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FR7325666A 1972-07-14 1973-07-12 Procede de production de preparations de cephalosporine Granted FR2275214A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7116372A JPS4930519A (enExample) 1972-07-14 1972-07-14

Publications (2)

Publication Number Publication Date
FR2275214A1 true FR2275214A1 (fr) 1976-01-16
FR2275214B1 FR2275214B1 (enExample) 1978-07-28

Family

ID=13452681

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7325666A Granted FR2275214A1 (fr) 1972-07-14 1973-07-12 Procede de production de preparations de cephalosporine

Country Status (3)

Country Link
JP (1) JPS4930519A (enExample)
ES (1) ES416907A1 (enExample)
FR (1) FR2275214A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033241A3 (en) * 1980-01-25 1982-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical compositions for rectal administration
EP0091502A1 (en) * 1982-04-13 1983-10-19 Asahi Kasei Kogyo Kabushiki Kaisha A pharmaceutical preparation of cephalosporin for rectal administration

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5336520B2 (enExample) * 1972-03-16 1978-10-03
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS55119771U (enExample) * 1979-01-23 1980-08-25

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033241A3 (en) * 1980-01-25 1982-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical compositions for rectal administration
EP0091502A1 (en) * 1982-04-13 1983-10-19 Asahi Kasei Kogyo Kabushiki Kaisha A pharmaceutical preparation of cephalosporin for rectal administration

Also Published As

Publication number Publication date
ES416907A1 (es) 1976-03-16
JPS4930519A (enExample) 1974-03-19
FR2275214B1 (enExample) 1978-07-28

Similar Documents

Publication Publication Date Title
ES427963A1 (es) Procedimiento para la preparacion de derivados de 5-metil-7-hidroxi-isoflavona.
CA981185A (en) Regenerative repeater output stage for bipolar coded message signals
GB792186A (en) Lubricating compositions
GB1203083A (en) A method for producing bearings
ES420992A1 (es) Procedimiento para la preparacion de soluciones estables enalmacenamiento de esteres de acido silicico parcialmente hi-drolizados y parcialmente condensados.
CA995686A (en) 3,5-dialkyl-4-hydroxyphenylalkanoic acid esters of polyalkylene glycols and compositions stabilized thereby
JPS5338690A (en) Isolation of co-enzyme q
CA1002236A (en) Preparation of powdered crosslinked polyalkylene oxides
FR2257268A1 (en) Collection and storage of bone marrow - under non oxidising conditions to prevent deterioration
CA991361A (en) Monocarboxylic acid esters of polyethylene glycol ethers
ES417985A1 (es) Procedimiento de preparacion de compuestos sicianosil-quer-cetina.
AU463573B2 (en) Trialkylsilyl ethers of 11-alkyl-17-alkynylestra-1, 3, 5(10)-trien-3, 17-diols
CA946818A (en) Derivatives of glycols, clycol ethers and glycol esters
AU455575B2 (en) Derivatives of glycols, glycol ethers and glycol esters
FR2199998A1 (en) Medicaments contg. sulpyrin suppositories - giving high blood sulpyrin concentrations
IE41358L (en) Acyloxymethyl cephalosporin compositions
AU3248671A (en) Polyglycidyl ethers of glycerine compositions
GB1374949A (en) Stable low current amplifier
JPS51133960A (en) Defoaming method
GB1364492A (en) Integrated circuit current source system
AU448880B2 (en) Mos bipolar push-pull output buffer
AU450503B2 (en) Novel alkaline protease. anda process for preparing thesame
FR2207988A1 (en) Stable aperitif - made from nutmeg cinnamon, vanilla, white rum, fruit juice and grenadine
ES386287A1 (es) Un proceso para preparar un nuevo derivado de polihidrofe- nantreno.
GB1402975A (en) Process for cleaving an allylic ether group in an allylic 2- alkoxy phenyl ether